In what situations/patient population would you consider placing an implantable cardiac monitor in favor of external monitors for long-term dynamic monitoring of atrial fibrillation?

This is an excellent question and I think we need the remainder of the publication to make our best estimates (specifically Table 1 and the n for results, including % ablated - couldn't find online or any pictures of slide data on Twitter). The online MONITOR-AF late-breaking trial abstract is available here.

I always like to see if the patient studied represents my patient. Note that this patient is different from the LOOP trial in that everyone already has atrial fibrillation, mean age ~ 75, as...